Stockscreener 앱 받기
25.55
1.27%
0.32
시간 외 거래:
25.56
0.010
+0.04%
전일 마감가:
$25.23
열려 있는:
$25.05
하루 거래량:
2.25M
Relative Volume:
0.66
시가총액:
$4.72B
수익:
$550.17M
순이익/손실:
$201.35M
주가수익비율:
25.55
EPS:
1
순현금흐름:
$232.07M
1주 성능:
+2.12%
1개월 성능:
-37.83%
6개월 성능:
-60.30%
1년 성능:
-65.93%
1일 변동 폭
$24.98
$25.91
1주일 범위
$24.30
$25.95
52주 변동 폭
$23.66
$76.51
Doximity Inc Stock (DOCS) Company Profile
명칭
Doximity Inc
전화
(650) 549-4330
주소
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
25.55 | 4.66B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
180.31 | 30.01B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
58.37 | 10.67B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
41.06 | 7.36B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.89 | 6.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
25.07 | 4.93B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2026-01-20 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | 개시 | RBC Capital Mkts | Outperform |
| 2026-01-08 | 업그레이드 | Truist | Hold → Buy |
| 2025-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-10-27 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-10-10 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-10-01 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-07-09 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-06-02 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2025-02-07 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | 개시 | Stephens | Equal-Weight |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Neutral |
| 2024-11-14 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2024-08-09 | 업그레이드 | Needham | Hold → Buy |
| 2024-07-18 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2024-01-02 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2023-08-09 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-08-09 | 다운그레이드 | Needham | Buy → Hold |
| 2023-08-03 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | 개시 | Wells Fargo | Overweight |
| 2022-10-24 | 개시 | Evercore ISI | In-line |
| 2022-10-13 | 개시 | BTIG Research | Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-07-28 | 개시 | Berenberg | Buy |
| 2022-05-18 | 재확인 | BofA Securities | Neutral |
| 2022-05-18 | 재확인 | Goldman | Buy |
| 2022-05-18 | 재확인 | Guggenheim | Buy |
| 2022-05-18 | 재확인 | Jefferies | Buy |
| 2022-05-18 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-05-18 | 재확인 | Needham | Buy |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-04 | 개시 | BofA Securities | Neutral |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2021-12-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-17 | 개시 | Robert W. Baird | Outperform |
| 2021-11-10 | 재확인 | Canaccord Genuity | Buy |
| 2021-11-10 | 재확인 | Goldman | Neutral |
| 2021-11-10 | 재확인 | Morgan Stanley | Equal-Weight |
| 2021-11-10 | 재확인 | Needham | Buy |
| 2021-11-10 | 재확인 | Piper Sandler | Overweight |
| 2021-08-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-19 | 개시 | Canaccord Genuity | Buy |
| 2021-07-19 | 개시 | Goldman | Neutral |
| 2021-07-19 | 개시 | JP Morgan | Overweight |
| 2021-07-19 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-07-19 | 개시 | Piper Sandler | Overweight |
| 2021-07-19 | 개시 | Raymond James | Outperform |
| 2021-07-19 | 개시 | SVB Leerink | Outperform |
| 2021-07-19 | 개시 | William Blair | Outperform |
모두보기
Doximity Inc 주식(DOCS)의 최신 뉴스
Piper Sandler raises Doximity stock price target on AI tools By Investing.com - Investing.com Australia
Doximity (NASDAQ:DOCS) Price Target Lowered to $33.00 at JPMorgan Chase & Co. - MarketBeat
Piper Sandler raises Doximity stock price target on AI tools - Investing.com
Piper Sandler Forecasts Strong Price Appreciation for Doximity (NASDAQ:DOCS) Stock - MarketBeat
Piper Sandler Raises Price Target for Doximity (DOCS) to $42 | D - GuruFocus
Doximity Stock: Why Analysts Are Signaling a Buy After a 67% Drop Last Year - TIKR.com
Doximity (DOCS) Soars 14% on Strong Earnings, Merger with AI-Powered Platform - MSN
Why Doximity Stock Plummeted Today - AOL.com
Canaccord Calls Doximity, Inc. (DOCS)’s Post-Earnings Selloff an Overreaction And Sees Long-Term Upside - Insider Monkey
Doximity Inc. (NYSE:DOCS) Fits the "Affordable Growth" Investment Strategy - ChartMill
How Doximity Inc. stock trades before earnings2025 AllTime Highs & Expert Verified Movement Alerts - mfd.ru
How Doximity Inc. stock performs in weak economyExit Point & Trade Opportunity Analysis - mfd.ru
Doximity (DOCS) Is Down 9.8% After Big Buybacks and Mixed Q3 Signals Has The Bull Case Changed? - Yahoo Finance
April 17th Options Now Available For Doximity (DOCS) - Nasdaq
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
Trend Recap: Is Doximity Inc stock suitable for long term investing2025 Market Trends & AI Driven Price Forecasts - baoquankhu1.vn
DOCS Stock Falls -30% With A 6-day Losing Spree On Weak Guidance - Trefis
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire
Halper Sadeh LLC Encourages Doximity Inc. Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Doximity's (NYSE:DOCS) Solid Earnings Have Been Accounted For Conservatively - Yahoo Finance
5 Revealing Analyst Questions From Doximity's Q4 Earnings Call - Finviz
Doximity Stock: Growth Outlook Is Murky (NYSE:DOCS) - Seeking Alpha
Barclays Maintains Doximity(DOCS.US) With Buy Rating, Cuts Target Price to $38 - 富途牛牛
Barclays Has Lowered Expectations for Doximity (NASDAQ:DOCS) Stock Price - MarketBeat
Allianz Asset Management GmbH Invests $5.72 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity (NASDAQ:DOCS) User Engagement Trends And Nyse Composite Market Reaction Explained - Kalkine Media
Quarterly Trades: Why is Doximity Inc stock going upJuly 2025 Setups & Technical Pattern Alert System - baoquankhu1.vn
Doximity (NASDAQ:DOCS) Price Target Lowered to $34.00 at Mizuho - MarketBeat
Mizuho lowers Doximity stock price target to $34 on pharma marketing delays - Investing.com Nigeria
Doximity (NYSE:DOCS) Raised to "Strong-Buy" at Canaccord Genuity Group - MarketBeat
Doximity, Inc. (DOCS) Stock Analysis: A Healthcare Tech Leader With 60% Upside Potential - DirectorsTalk Interviews
William Blair Dumps $21 Million of Healthcare Platform Doximity Stock - AOL.com
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More - AOL.com
Here Are Monday’s Top Wall Street Analyst Research Calls: Autozone, Doximity, Li Auto, Oracle, Robinhood Markets, Roblox, SoFi Technolgy, Terawulf and More - AOL.com
Canaccord Genuity Upgrades Doximity to Buy From Hold, Adjusts Price Target to $34 From $48 - marketscreener.com
Canaccord Genuity upgrades Doximity stock to Buy on valuation By Investing.com - Investing.com UK
Canaccord Genuity upgrades Doximity stock to Buy on valuation - Investing.com
Assessing Doximity (DOCS) Valuation After A Sharp Pullback And Ongoing Profitability - Yahoo Finance
Doximity (DOCS) Earnings Call: AI, Buybacks and Growth - TipRanks
Doximity (NYSE:DOCS) Rating Increased to Moderate Buy at Needham & Company LLC - MarketBeat
Doximity Stock (-17%): Weak Guidance Sparks an Institutional Sell-Off - Trefis
JPMorgan upgrades Doximity stock rating to Neutral from Underweight By Investing.com - Investing.com Nigeria
Truist Securities lowers Doximity stock price target to $37 on growth concerns By Investing.com - Investing.com South Africa
Needham lowers Doximity stock price target to $55 on mixed earnings - Investing.com UK
Doximity (DOCS) Stock Plummets 17% on Weak Guidance and AI Cost Surges - FinancialContent
Doximity stock dives as Q4 outlook rattles investors despite $500 million buyback - TechStock²
Doximity, Inc.'s (NYSE:DOCS) Popularity With Investors Under Threat As Stock Sinks 27% - simplywall.st
Doximity (NYSE:DOCS) Shares Gap DownWhat's Next? - MarketBeat
Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates - Yahoo Finance
Why Doximity stock plummeted today - MSN
Doximity Inc (DOCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.79%
0.73%
자본화:
|
볼륨(24시간):